EUVIMEDObjevte EUVIMED
Crossref

Dual-Targeted Codelivery of XBP1 Inhibitor and Photosensitizer by GSH-Responsive Functional Silica Nanoparticles for Enhanced Photoimmunotherapy

Baoyuan Li, Fengying Cui, Jingyuan Suo, Xiangjun Chen iD, Jinrong Peng iD, Wei Hong iD, Wenting Li iD

ACS Applied Materials & Interfaces · 2026-04-29 · 18 (16) · 22944-22960

DOI: 10.1021/acsami.6c02486 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, published online on 2026-04-15. Written by Baoyuan Li and 6 co-authors. Institution: Qingdao University, Yantai Yuhuangding Hospital, Department of Otolaryngology Head & Neck Surgery, Yantai 264000, P. R. China. Major MEDLINE topics: Nanoparticles, Photosensitizing Agents, X-Box Binding Protein 1, Silicon Dioxide. 37 references. Funded by: Natural Science Foundation of Shandong Province, Key Research and Development Program of Sichuan Province, National Natural Science Foundation of China (NSFC).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Subjects

MeSH terms (MEDLINE)

NanoparticlesPhotosensitizing AgentsX-Box Binding Protein 1Silicon DioxideImmunotherapyAnimalsMiceFemaleGlutathioneCell Line, TumorHumansMice, Inbred BALB CEndoplasmic Reticulum Stressbeta-Cyclodextrins

Author keywords

Antitumor combination therapyEndoplasmic reticulum stressMitochondrial dysfunctionPhotoimmunotherapyTargeting codelivery

Substances

Photosensitizing AgentsX-Box Binding Protein 1Silicon DioxideGlutathioneXbp1 protein, mousebeta-Cyclodextrins

Authors and institutions

  • Qingdao University, Yantai Yuhuangding Hospital, Department of Otolaryngology Head & Neck Surgery, Yantai 264000, P. R. China.
  • School of Pharmacy, Shandong New Drug Loading & Release Technology and Preparation Engineering Laboratory, Binzhou Medical University, 346 Guanhai Road, Yantai 264003, P. R. China.
  • State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, Sichuan 610041, P. R. China.

ORCID profiles: Xiangjun Chen, Jinrong Peng, Wei Hong, Wenting Li

Funding

  • Natural Science Foundation of Shandong Province
  • Key Research and Development Program of Sichuan Province
  • National Natural Science Foundation of China (NSFC)
  • Provincial-Level Leading Talent Sponsorship Program by Yantai

Cite

APA

Li, B., Cui, F., Suo, J., Chen, X., Peng, J., Hong, W., & Li, W. (2026). Dual-Targeted Codelivery of XBP1 Inhibitor and Photosensitizer by GSH-Responsive Functional Silica Nanoparticles for Enhanced Photoimmunotherapy. ACS Applied Materials & Interfaces, 18(16), 22944-22960. https://doi.org/10.1021/acsami.6c02486

Vancouver

Li B, Cui F, Suo J, Chen X, Peng J, Hong W, et al. Dual-Targeted Codelivery of XBP1 Inhibitor and Photosensitizer by GSH-Responsive Functional Silica Nanoparticles for Enhanced Photoimmunotherapy. ACS Applied Materials & Interfaces. 2026;18(16):22944-22960. doi:10.1021/acsami.6c02486

BibTeX
@article{Li2026,
  author = {Li, Baoyuan and Cui, Fengying and Suo, Jingyuan and Chen, Xiangjun and Peng, Jinrong and Hong, Wei and Li, Wenting},
  title = {Dual-Targeted Codelivery of XBP1 Inhibitor and Photosensitizer by GSH-Responsive Functional Silica Nanoparticles for Enhanced Photoimmunotherapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  volume = {18},
  number = {16},
  pages = {22944--22960},
  doi = {10.1021/acsami.6c02486}
}
Start for free →